颅内出血手术患者的抗血小板药物逆转策略:执业神经外科医生调查
一项面向北美执业神经外科医生的在线调查,评估急性手术性颅内出血(硬膜下血肿、硬膜外血肿、脑出血)患者的抗血小板逆转策略。2782个有效邮箱中493人(17.7%)回答第1题、429人(15.4%)完成问卷。多数受访者术前不做额外实验室检查;阿司匹林最常见策略为血小板输注(硬膜下血肿和脑出血)或不干预(硬膜外血肿);ADP拮抗剂或双联抗血小板治疗最常见为血小板输注或血小板输注联合醋酸去氨加压素;管理策略随抗血小板药物不同有统计学显著差异(P < 0.001)。
要点
- 多数神经外科医生在手术性颅内出血术前不进行定性血小板功能检测。
- 阿司匹林相关硬膜下血肿和脑出血最常见逆转策略为血小板输注,硬膜外血肿为不干预。
- ADP拮抗剂或双联抗血小板治疗时最常见为血小板输注或血小板输注联合醋酸去氨加压素。
核心结论
- 抗血小板药物患者发生手术性颅内出血时,多数神经外科医生不进行定性血小板检测。
- 抗血小板逆转策略显著受抗血小板药物类型影响,ADP拮抗剂存在时采用更积极的逆转策略。
研究设计与样本
- 在线问卷调查,面向北美委员会认证的神经外科医生,涉及急性手术性颅内出血(硬膜下血肿、硬膜外血肿、脑出血)的抗血小板逆转策略。
- 从2782个有效电子邮箱发出,493人(17.7%)回答第1题,429人(15.4%)完成问卷。
主要发现
- 多数受访者无论出血类型均选择术前不进行额外实验室检查。
- 阿司匹林存在时,硬膜下血肿和脑出血最常见策略为血小板输注,硬膜外血肿为不干预。
- ADP拮抗剂或双联抗血小板治疗时,最常见策略为血小板输注或血小板输注联合醋酸去氨加压素。
- 管理策略随抗血小板治疗不同有统计学显著差异(P < 0.001)。
关键数值与推荐
- 阿司匹林相关硬膜下血肿:最常见为血小板输注。
- 阿司匹林相关脑出血:最常见为血小板输注。
- 阿司匹林相关硬膜外血肿:最常见为不干预。
- ADP拮抗剂或双联抗血小板治疗:最常见为血小板输注或血小板输注联合醋酸去氨加压素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antiplatelet therapy is common and complicates operative management of acute intracranial hemorrhage. Few data exist to guide antiplatelet reversal strategies. METHODS: An online survey detailing antiplatelet reversal strategies in patients presenting with acute operative intracranial hemorrhage (subdural hematoma, epidural hematoma, and intracerebral hemorrhage) was distributed to board-certified neurosurgeons in North America. RESULTS: From 2782 functional e-mail addresses, there were 493 (17.7%) responses to question 1 and 429 (15.4%) completed surveys. Most respondents chose to perform no additional laboratory testing before surgical intervention, regardless of hemorrhage type. The most common antiplatelet reversal strategy in the presence of aspirin was platelet transfusion (subdural hematoma and intracerebral hemorrhage) or no intervention (epidural hematoma). The most common antiplatelet reversal strategy in the presence of an adenosine diphosphate antagonist or dual antiplatelet therapy was platelet transfusion or platelet transfusion with desmopressin acetate administration. There was a statistically significant difference in management strategy depending on the antiplatelet therapy (P < 0.001). CONCLUSIONS: When patients on antiplatelet medication present with operative intracranial hemorrhage, the majority of neurosurgeons do not perform qualitative platelet testing. Antiplatelet reversal strategies are significantly influenced by the antiplatelet therapy with more aggressive reversal strategies employed in the presence of ADP antagonists.
引用
- Foreman PM, Ilyas A, Mooney J, et al. Antiplatelet Medication Reversal Strategies in Operative Intracranial Hemorrhage: A Survey of Practicing Neurosurgeons. World Neurosurg. 2018. PMID: 29783009. doi:10.1016/j.wneu.2018.05.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。